default author photo

Ravindra K. Gupta

Cambridge Institute of Therapeutic Immunology & Infectious Disease

Cambridge CB2 0AW

United Kingdom

University of Cambridge - Department of Medicine

Cambridge CB2 0AW

United Kingdom

SCHOLARLY PAPERS

6

DOWNLOADS

513

TOTAL CITATIONS

50

Scholarly Papers (6)

1.

Age-Related Heterogeneity in Neutralising Antibody Responses to SARS-CoV-2 Following BNT162b2 Vaccination

Number of pages: 18 Posted: 11 Feb 2021
University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University College London - Division of Infection and Immunity, NIHR Cambridge Clinic Research Facility - Addenbrooke's Hospital, NIHR Cambridge Biomedical Research Centre - NIHR BioResource, NIHR BioResource, NIHR Cambridge Biomedical Research Centre, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, NIHR Cambridge Clinic Research Facility - Addenbrooke's Hospital, Addenbrookes Hospital - Department of Clinical Biochemistry and Immunology, NIHR Cambridge Clinical Research Facility, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease and Cambridge Institute of Therapeutic Immunology & Infectious Disease
Downloads 254 (301,349)
Citation 1

Abstract:

Loading...

SARS-CoV-2; COVID-19; antibody; vaccine; neutralising antibodies

2.

B Cell Receptor Repertoire Kinetics after SARS-CoV-2 Infection and Vaccination

Number of pages: 51 Posted: 24 Aug 2021
University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Addenbrooke's Hospital - Division of Virology, University Hospital Basel - Immunobiology Laboratory, NHS Foundation Trust - Cambridge University Hospitals, University of Cambridge - Division of Virology, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease and University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease
Downloads 121 (596,393)

Abstract:

Loading...

3.

Early Immune Pathology and Persistent Dysregulation Characterise Severe COVID-19

Number of pages: 105 Posted: 29 Dec 2020
University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - MRC Biostatistics Unit, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Department of Medicine, NIHR Cambridge Clinical Research Facility, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, NIHR Cambridge Clinic Research Facility - Addenbrooke's Hospital, University of Cambridge - Division of Virology, Cambridge Institute of Therapeutic Immunology & Infectious Disease, Addenbrooke's Hospital - Division of Virology, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, NIHR Cambridge Biomedical Research Centre - NIHR BioResource, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Murdoch University - The Centre for Computational and Systems Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, University of Cambridge - MRC Biostatistics Unit, NIHR Cambridge Clinic Research Facility - Addenbrooke's Hospital, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease, Hycult Biotech - R&D Department, University of Cambridge - Cambridge Institute for Medical Research, Independent, Royal Papworth HospitalUniversity of Cambridge - Heart and Lung Research Institute, University Hospital Basel - Immunobiology Laboratory, University of Cambridge - Department of Medicine, University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease and University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease
Downloads 60 (970,490)

Abstract:

Loading...

4.

Recurrent Emergence and Transmission of a SARS-CoV-2 Spike Deletion H69/V70

Number of pages: 29 Posted: 05 Feb 2021
Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge Institute of Therapeutic Immunology & Infectious Disease, Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Glasgow - Institute of Biodiversity, Animal Health and Comparative Medicine, Cambridge Institute of Therapeutic Immunology & Infectious Disease, MRC - University of Glasgow Centre for Virus Research, MRC – Laboratory of Molecular Biology, Independent, University of Cambridge - Department of Medicine, University of Cambridge - Department of Medicine, University of Cambridge - Department of Medicine, MRC – Laboratory of Molecular Biology, MRC - University of Glasgow Centre for Virus Research and Cambridge Institute of Therapeutic Immunology & Infectious Disease
Downloads 42 (1,170,409)
Citation 49

Abstract:

Loading...

SARS-CoV-2; COVID-19; antibody escape; neutralising antibodies; mutation; 37 evasion; resistance; fitness; evolution

5.

Hypoxia Drives HIF2-Dependent Reversible Macrophage Cell Cycle Entry

Number of pages: 25 Posted: 22 Mar 2024
University of Cambridge, University of Oxford, University of Cambridge, University of Cambridge, University of Cambridge, University of Oxford, University of Cambridge, University of Oxford, The Babraham Institute, University of Cambridge, University of Cambridge and Cambridge Institute of Therapeutic Immunology & Infectious Disease
Downloads 25 (1,411,822)

Abstract:

Loading...

Macrophage, cell cycle, SAMHD1, lentivirus, Cell division

6.

SARS-CoV-2 Intra-Host Recombination Promotes Epistatic Interactions in Spike and Emergence of Successful Variants

Number of pages: 54 Posted: 11 Feb 2026
University of Cambridge, University of Cambridge, University of Vigo, CSIR-Institute of Genomics and Integrative Biology, University of Cambridge, Independent, University of Cape Town, University of Cape Town, CSIR-Institute of Genomics and Integrative Biology, University of Cambridge and Cambridge Institute of Therapeutic Immunology & Infectious Disease
Downloads 11 (1,548,648)

Abstract:

Loading...

COVID-19, recombination, syncytia, spike cleavage, immune evasion, mutation, SARS CoV 2